Edwards Lifesciences EW Rest of World — Selling, general, and administrative expenses
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The official record: Edwards Lifesciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Edwards Lifesciences's rest of world — selling, general, and administrative expenses.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Edwards Lifesciences's rest of world — selling, general, and administrative expenses?
- Edwards Lifesciences (EW) reported rest of world — selling, general, and administrative expenses of $48M in Q1 2026.
- How has Edwards Lifesciences's rest of world — selling, general, and administrative expenses changed year-over-year?
- Edwards Lifesciences's rest of world — selling, general, and administrative expenses increased by 14.0% year-over-year, from $42.1M to $48M.
- What is the long-term trend for Edwards Lifesciences's rest of world — selling, general, and administrative expenses?
- Over 3 years (2022 to 2025), Edwards Lifesciences's rest of world — selling, general, and administrative expenses has grown at a 13.7% compound annual growth rate (CAGR), from $142.6M to $209.6M.
- What does rest of world — selling, general, and administrative expenses mean?
- This metric tracks the operating expenses incurred to support sales, marketing, and administrative functions within the Rest of World segment. It includes costs for sales force compensation, medical education programs, and regional administrative overhead required to maintain operations in these territories. High spending here is often necessary to drive market adoption in newer or rapidly growing international regions.